Filter Results:
(2,084)
Show Results For
- All HBS Web
(2,084)
- People (8)
- News (589)
- Research (987)
- Events (3)
- Multimedia (25)
- Faculty Publications (581)
Show Results For
- All HBS Web
(2,084)
- People (8)
- News (589)
- Research (987)
- Events (3)
- Multimedia (25)
- Faculty Publications (581)
- January 2018
- Article
The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials
By: Aaron V. Kaplan and Ariel D. Stern
The introduction of new medical devices has transformed cardiovascular care in recent decades. Devices, such as heart valves, pacemakers, stents, ventricular assist devices, and implantable defibrillators, have prolonged and improved the quality of life for millions of... View Details
Keywords: Health Testing and Trials; Business and Government Relations; Governing Rules, Regulations, and Reforms; Information Publishing; Medical Devices and Supplies Industry; United States
Kaplan, Aaron V., and Ariel D. Stern. "The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials." JAMA Cardiology 3, no. 1 (January 2018): 5–6.
- November 2021 (Revised December 2021)
- Case
Praava Health: A New Model for Bangladesh
By: Michael Chu
Launched in Dhaka, Bangladesh, in 2018, Praava Health (‘Praava’) delivered high-quality in-clinic primary and specialist care, backed by its own high quality diagnostic laboratories, imaging and pharmacy. Praava was founder Sylvana Sinha’s response to what she saw as a... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Investment Return; Mobile and Wireless Technology; Business Model; Growth and Development Strategy; Health Industry; Bangladesh; Asia
Chu, Michael. "Praava Health: A New Model for Bangladesh." Harvard Business School Case 322-067, November 2021. (Revised December 2021.)
- Web
Doctoral
the changing world of business, society, and education. PhD Programs Accounting & Management Business Economics (Includes Finance) Health Policy (Management) Marketing Organizational Behavior Strategy View Details
- February 2019 (Revised September 2019)
- Case
Theranos: The Unicorn That Wasn't
By: Joseph B. Fuller and John Masko
In 2003, 19-year-old Elizabeth Holmes founded a startup dedicated to making blood testing easier and more affordable. By 2015, her company, Theranos, was worth $9 billion. It boasted a star-studded board and contracts with national pharmacy and supermarket chains... View Details
Keywords: Theranos; Blood; Lab Testing; Fraud; Holmes; Balwani; Shultz; Carreyrou; Securities And Exchange Commission; Food And Drug Administration; FDA; SEC; Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Medical Devices and Supplies Industry
Fuller, Joseph B., and John Masko. "Theranos: The Unicorn That Wasn't." Harvard Business School Case 319-068, February 2019. (Revised September 2019.)
- December 2008 (Revised April 2010)
- Case
Proteus Biomedical: Making Pigs Fly
By: Richard G. Hamermesh, Lauren Barley and Ginger Graham
Proteus is a healthcare start-up that has developed technology to embed electronics for computing and sensing in existing medical devices and drugs. The technology could potentially change the basis of competition in the pharmaceutical industry. The company is... View Details
Keywords: Business Startups; Entrepreneurship; Technological Innovation; Rights; Negotiation Deal; Business Strategy; Health Industry; Health Industry; Health Industry
Hamermesh, Richard G., Lauren Barley, and Ginger Graham. "Proteus Biomedical: Making Pigs Fly." Harvard Business School Case 809-051, December 2008. (Revised April 2010.)
- Web
Class Profile - MBA
use a 4.0 grading system) 143 Domestic Universities 153 International Universities Pre-MBA Industry Consulting Consumer Products / Retail / E-Commerce Financial Services Health Care / Biotech Manufacturing / Industrial / Energy Media /... View Details
- 25 Feb 2015
- News
Scholars and Students Unpack the Digital Business Revolution
- 12 Aug 2019
- Working Paper Summaries
Case Histories of Significant Medical Advances
- 17 May 2012
- News
Study: Safety inspections don't hurt profits
- August 17, 2016
- Article
How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures
By: Kevin P. Shah, Tracy E. Spinks and Thomas W. Feeley
In 2014, The University of Texas MD Anderson Cancer Center created a streamlined process for developing measure sets for patient-centered outcomes, including provider-generated and patient-reported outcomes, at an accelerated pace. These comprehensive sets are... View Details
Keywords: Information Technology; Measurement and Metrics; Quality; Service Delivery; Health Care and Treatment; Health Industry; Texas
Shah, Kevin P., Tracy E. Spinks, and Thomas W. Feeley. "How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures." NEJM Catalyst (August 17, 2016).
- 2016
- Article
Integrated Care from the Patient's Perspective and its Relationship to Medical Group Attributes.
By: Michaela Kerrissey, Jonathan Clark, Ashley-Kay Fryer, Wei Jiang, Maryaline Catillon, Patricia Ramsay, Stephen Shortell, Lawrence Casalino, Mark Friedberg and Sara J. Singer
Integrating care for patients with multiple chronic conditions is essential to improving quality. Yet little is known about care integration from the patient’s perspective and how it relates to medical group characteristics. We created a nationally representative... View Details
Keywords: Care Coordination; Integrated Care; Health; Health Care and Treatment; Quality; Perspective; Health Industry
Kerrissey, Michaela, Jonathan Clark, Ashley-Kay Fryer, Wei Jiang, Maryaline Catillon, Patricia Ramsay, Stephen Shortell, Lawrence Casalino, Mark Friedberg, and Sara J. Singer. "Integrated Care from the Patient's Perspective and its Relationship to Medical Group Attributes." Academy of Management Proceedings (2016).
Dutch Leonard
Herman B. ("Dutch") Leonard is Eliot I. Snider and Family Professor of Business Administration at the Harvard Business School and the George F. Baker, Jr. Professor of Public Sector Management at Harvard University's John F. Kennedy School of Government. In... View Details
- 23 Mar 2020
- Research & Ideas
Product Disasters Can Be Fertile Ground for Innovation
technological complexity only magnifies the challenge. Many companies, meanwhile, are apt to see investment in safety as the cost of fulfilling regulatory requirements or protecting against lawsuits, rather than as an opportunity to... View Details
- 17 Apr 2018
- Working Paper Summaries
Digital Innovation with High Costs of Entry: Evidence from Software-Driven Medical Devices
- 21 Jan 2021
- Blog Post
How I Used the HBS Community to Hone My Professional Goals
straightforward as I thought it would be. Of course, everything looks perfectly planned and linear in retrospect, but in reality, it definitely was not for me and I pivoted a couple of times. I started my first (RC) year at HBS focused on internship recruiting for... View Details
- Research Summary
Current Research
By: Leslie K. John
Professor John is a behavioral scientist who uses both laboratory and field experiments to investigate questions that are at the intersection of marketing, organizational behavior, and public policy.
Professor John’s work has been published in leading... View Details
- Program
General Management Program
organization, the program delivers the tools you need to capitalize on technological disruption and digital transformation and play a more strategic role in corporate success. This includes: Read More Considering global and industry... View Details
Frances X. Frei
Frances Frei is a Professor of Technology and Operations Management at Harvard Business School. Her research investigates how leaders create the conditions for organizations and individuals to thrive by designing for excellence in operations, strategy, and culture.... View Details
- 20 Nov 2018
- First Look
New Research and Ideas, November 20, 2018
Abstract—In a survey of the NEJM Catalyst Insights Council in July 2018, 42% of respondents say they think value-based reimbursement models will be the primary revenue model for U.S. health care. Indeed, this transition is already... View Details
Keywords: Dina Gerdeman